Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
21. |
ECCT/14/05/02 | Invivo I study In vivo and in vitro efficacy of artemisinin combination therapy in Kisumu County, Western Kenya. |
Principal Investigator(s) 1. Ben Andagalu Site(s) in Kenya Kombewa Clinical Research Center |
View |
22. |
ECCT/14/05/03 | Invivo II study Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria in Kisumu County, Western Kenya Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria in Kisumu County, Western Kenya |
Principal Investigator(s) 1. Ben Andagalu Site(s) in Kenya Kombewa Clinical Research Center |
View |
23. |
ECCT/14/07/01 | POST STABILIZATION VERSUS URGENT START OF HAART IN HIV-1 INFECTED CHILDREN WITH SEVERE COINFECTION |
Principal Investigator(s) 1. Grace John-Stewart Site(s) in Kenya 1. Kenyatta National Hospital (Nairobi City county) 2. Jaramogi Odinga Teaching and Referral Hospital (Kisumu county) 3. Kisumu East District Hospital (Kisumu county) |
View |
24. |
ECCT/14/12/01 | Rivaroxaban for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE) XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE) in Latin America, EMEA and Asia |
Principal Investigator(s) 1. Anne Njeri Mugera Njambi Mugera 2. Dr. Martin N Wanyoike Njoroge Wanyoike 3. Charles Muthui Kariuki Muthui Kariuki 4. FEROZ ALI Allibhoy Site(s) in Kenya 1. Primecare Heart Clinic (Nairobi City county) 2. Dr. Silversteins Clinic (Nairobi City county) 3. Nairobi Cardiovascular Clinic (Nairobi City county) 4. Agah Khan Kisumu (Kisumu county) |
View |
25. |
ECCT/15/01/02 | Study title An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya. Clinical Phase IV |
Principal Investigator(s) 1. Prof Walter Jaoko Jaoko Site(s) in Kenya KAVI-INSTITUTE OF CLINICAL RESEARCH (KAVI-ICR) |
View |